- Emerging Trends in Cancer Prevention Agent Development
-
Miller MS, Mohammed A
- KMID: 2541585
- J Cancer Prev.
- 2023 Mar;28(1):24-28.
- doi: 10.15430/JCP.2023.28.1.24
Advances in omics and immunology over the past 20 years have revolutionized the approach to cancer prevention, with the goal now focused on identifying populations at higher risk for developing... -
- CITED
-
- Close
- SHARE
-
- Close
- Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
-
Mohammed A, Dashwood RH, Dickinson S, Disis ML, Jaffee EM, Johnson 6 BD, Khleif SN, Pollak MN, Schlom J, Shoemaker RH, Stanton SE, Wondrak GT, You M, Zhu H, Miller MS
- KMID: 2524126
- J Cancer Prev.
- 2021 Dec;26(4):309-317.
- doi: 10.15430/JCP.2021.26.4.309
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on... -
- CITED
-
- Close
- SHARE
-
- Close
- Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
-
Miller MS, Allen PJ, Brown PH, Chan AT, Clapper ML, Dashwood RH, Demehri S, Disis ML, DuBois RN, Glynn RJ, Kensler TW, Khan SA, Johnson BD, Liby KT, Lipkin SM, Mallery SR, Meuillet EJ, Roden RB, Schoen RE, Sharp ZD, Shirwan H, Siegfried JM, Rao CV, You M, Vilar E, Szabo E, Mohammed A
- KMID: 2514697
- J Cancer Prev.
- 2021 Mar;26(1):71-82.
- doi: 10.15430/JCP.2021.26.1.71
The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention... -
- CITED
-
- Close
- SHARE
-
- Close
